Disc Medicine’s effort to introduce a new therapy for a rare blood disorder with few treatment options has been derailed with the FDA turning down the application and asking for more data from another ...

Join MachineGunDanny and his son on an action-packed toy hunt as they search Walmart for the latest X-Shot Insanity Horrorfire blasters! Watch as they unbox and test the Reaper X, Doomsday, and Dread ...

Twin Disc beat estimated earnings by 1007.0%, reporting an EPS of $1.55 versus an estimate of $0.14. Revenue was up $259 thousand from the same period last year. Last quarter the company missed on EPS ...

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Disc Medicine (IRON) has drawn fresh attention after securing priority FDA review for ...

Investing.com - Morgan Stanley has reiterated an Overweight rating and $120.00 price target on Disc Medicine (NASDAQ:IRON) following reports about potential FDA review extensions for CNPV drugs. This ...

Two drugs developed by Disc Medicine (IRON) and Sanofi (SNY) are facing delays in their review timelines due to safety and efficacy concerns in the U.S. after being selected for the FDA Commissioner’s ...

A documentary tracks the highs and lows of the 1990s fitness guru, now a food delivery driver in Las Vegas. By Glenn Kenny When you purchase a ticket for an independently reviewed film through our ...

Add Yahoo as a preferred source to see more of our stories on Google. Zeberiah Newman’s Stop the Insanity: Finding Susan Powter is not your typical exercise in rise-and-fall ’90s celebrity nostalgia.

Zeberiah Newman's documentary finds Susan Powter in Las Vegas and explores her life, celebrity and hopes for a comeback. By Daniel Fienberg Chief Television Critic Then again, Susan Powter was never ...

There are good albums and great albums, and then there are holy records — worlds you enter as if into a dream and emerge with spirit and neurochemistry changed. Bruce Springsteen’s 1982 classic ...

The Food and Drug Administration announced on Thursday the first round of experimental drugs to be included in a priority voucher program. This FDA initiative is designed to expedite drug review ...